Class information for:
Level 1: TETRATHIOMOLYBDATE//CLIOQUINOL//UNITA RIC CATANIA

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
25841 270 43.7 80%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
4 4 ENVIRONMENTAL SCIENCES//GEOSCIENCES, MULTIDISCIPLINARY//METEOROLOGY & ATMOSPHERIC SCIENCES 1766162
184 3       METALLOTHIONEIN//WILSONS DISEASE//CADMIUM 56156
1113 2             WILSONS DISEASE//METALLOTHIONEIN//ATP7B 9713
25841 1                   TETRATHIOMOLYBDATE//CLIOQUINOL//UNITA RIC CATANIA 270

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 TETRATHIOMOLYBDATE authKW 1017801 11% 30% 30
2 CLIOQUINOL authKW 890798 11% 25% 31
3 UNITA RIC CATANIA address 628289 4% 56% 10
4 ANTICOPPER THERAPY authKW 339281 1% 100% 3
5 IBDML UMR CNRS 6216 address 226187 1% 100% 2
6 QUINOLIN 8 OL HALOGEN DERIVATIVES authKW 226187 1% 100% 2
7 ATN 224 authKW 203566 1% 60% 3
8 IBDML UMR 6216 address 201051 1% 44% 4
9 COPPER CHELATION authKW 195609 3% 22% 8
10 TRIENTINE authKW 185577 3% 21% 8

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 Oncology 579 25% 0% 68
2 Chemistry, Medicinal 474 13% 0% 35
3 Chemistry, Inorganic & Nuclear 123 9% 0% 23
4 Biochemistry & Molecular Biology 98 20% 0% 53
5 Crystallography 54 4% 0% 12
6 Pharmacology & Pharmacy 54 11% 0% 29
7 Medicine, Research & Experimental 52 6% 0% 17
8 Cell Biology 25 7% 0% 19
9 Medical Laboratory Technology 25 2% 0% 5
10 Chemistry, Multidisciplinary 13 8% 0% 21

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 UNITA RIC CATANIA 628289 4% 56% 10
2 IBDML UMR CNRS 6216 226187 1% 100% 2
3 IBDML UMR 6216 201051 1% 44% 4
4 TAUBMAN HLTH 1904 150790 1% 67% 2
5 BMSS 113094 0% 100% 1
6 CONSORZIO INTERUNIV RIC CHIM METALLI SISTEMI BIOL 113094 0% 100% 1
7 DAVIS HEART LUNG 512 MOL MED 113094 0% 100% 1
8 IBDMLUMR 6216CNRS 113094 0% 100% 1
9 INSERM 631 113094 0% 100% 1
10 INSERMJEAN PIERRE AUBERT 113094 0% 100% 1

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 MEDCHEMCOMM 3008 2% 0% 6
2 TRANSLATIONAL RESEARCH 1887 1% 0% 4
3 JOURNAL OF TRACE ELEMENTS IN EXPERIMENTAL MEDICINE 1572 1% 1% 2
4 JOURNAL OF INORGANIC BIOCHEMISTRY 1276 3% 0% 8
5 EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY 1202 4% 0% 10
6 CURRENT CANCER DRUG TARGETS 1065 1% 0% 3
7 EXPERIMENTAL BIOLOGY AND MEDICINE 683 1% 0% 4
8 EJHP PRACTICE 566 0% 1% 1
9 CHEMPLUSCHEM 499 1% 0% 2
10 POLYCYCLIC AROMATIC COMPOUNDS 468 1% 0% 2

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 TETRATHIOMOLYBDATE 1017801 11% 30% 30 Search TETRATHIOMOLYBDATE Search TETRATHIOMOLYBDATE
2 CLIOQUINOL 890798 11% 25% 31 Search CLIOQUINOL Search CLIOQUINOL
3 ANTICOPPER THERAPY 339281 1% 100% 3 Search ANTICOPPER+THERAPY Search ANTICOPPER+THERAPY
4 QUINOLIN 8 OL HALOGEN DERIVATIVES 226187 1% 100% 2 Search QUINOLIN+8+OL+HALOGEN+DERIVATIVES Search QUINOLIN+8+OL+HALOGEN+DERIVATIVES
5 ATN 224 203566 1% 60% 3 Search ATN+224 Search ATN+224
6 COPPER CHELATION 195609 3% 22% 8 Search COPPER+CHELATION Search COPPER+CHELATION
7 TRIENTINE 185577 3% 21% 8 Search TRIENTINE Search TRIENTINE
8 5 7 DIBROMO 8 QUINOLINOL 113094 0% 100% 1 Search 5+7+DIBROMO+8+QUINOLINOL Search 5+7+DIBROMO+8+QUINOLINOL
9 5 7 DICHLORO 8 QUINOLINOLINE 113094 0% 100% 1 Search 5+7+DICHLORO+8+QUINOLINOLINE Search 5+7+DICHLORO+8+QUINOLINOLINE
10 5 7 DIHALO 8 QUINOLINOL TINIV COMPLEX 113094 0% 100% 1 Search 5+7+DIHALO+8+QUINOLINOL+TINIV+COMPLEX Search 5+7+DIHALO+8+QUINOLINOL+TINIV+COMPLEX

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref.
in cl.		 Shr. of ref. in
cl.		 Citations
1 BREWER, GJ , (2014) THE PROMISE OF COPPER LOWERING THERAPY WITH TETRATHIOMOLYBDATE IN THE CURE OF CANCER AND IN THE TREATMENT OF INFLAMMATORY DISEASE.JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY. VOL. 28. ISSUE 4. P. 372 -378 28 80% 5
2 OLIVERI, V , VECCHIO, G , (2016) 8-HYDROXYQUINOLINES IN MEDICINAL CHEMISTRY: A STRUCTURAL PERSPECTIVE.EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY. VOL. 120. ISSUE . P. 252 -274 44 28% 4
3 CROWE, A , JACKAMAN, C , BEDDOES, KM , RICCIARDO, B , NELSON, DJ , (2013) RAPID COPPER ACQUISITION BY DEVELOPING MURINE MESOTHELIOMA: DECREASING BIOAVAILABLE COPPER SLOWS TUMOR GROWTH, NORMALIZES VESSELS AND PROMOTES T CELL INFILTRATION.PLOS ONE. VOL. 8. ISSUE 8. P. - 24 52% 7
4 MEDICI, V , STURNIOLO, GC , (2008) TETRATHIOMOLYBDATE, A COPPER CHELATOR FOR THE TREATMENT OF WILSON DISEASE, PULMONARY FIBROSIS AND OTHER INDICATIONS.IDRUGS. VOL. 11. ISSUE 8. P. 592 -606 26 50% 10
5 MCCUBBIN, MD , HOU, GQ , ABRAMS, GD , DICK, R , ZHANG, Z , BREWER, GJ , (2006) TETRATHIOMOLYBDATE IS EFFECTIVE IN A MOUSE MODEL OF ARTHRITIS.JOURNAL OF RHEUMATOLOGY. VOL. 33. ISSUE 12. P. 2501-2506 20 67% 7
6 ASKARI, F , INNIS, D , DICK, RB , HOU, GQ , MARRERO, J , GREENSON, J , BREWER, GJ , (2010) TREATMENT OF PRIMARY BILIARY CIRRHOSIS WITH TETRATHIOMOLYBDATE: RESULTS OF A DOUBLE-BLIND TRIAL.TRANSLATIONAL RESEARCH. VOL. 155. ISSUE 3. P. 123 -130 14 74% 7
7 BREWER, GJ , (2012) METALS IN THE CAUSATION AND TREATMENT OF WILSON'S DISEASE AND ALZHEIMER'S DISEASE, AND COPPER LOWERING THERAPY IN MEDICINE.INORGANICA CHIMICA ACTA. VOL. 393. ISSUE . P. 135-141 22 42% 15
8 BREWER, GJ , DICK, R , ZENG, CH , HOU, GQ , (2006) THE USE OF TETRATHIOMOLYBDATE IN TREATING FIBROTIC, INFLAMMATORY, AND AUTOIMMUNE DISEASES, INCLUDING THE NON-OBESE DIABETIC MOUSE MODEL.JOURNAL OF INORGANIC BIOCHEMISTRY. VOL. 100. ISSUE 5-6. P. 927-930 17 63% 10
9 HOU, GQ , DICK, R , ZENG, CH , BREWER, GJ , (2006) COMPARISON OF LOWERING COPPER LEVELS WITH TETRATHIOMOLYBDATE AND ZINC ON MOUSE TUMOR AND DOXORUBICIN MODELS.TRANSLATIONAL RESEARCH. VOL. 148. ISSUE 6. P. 309-314 14 67% 5
10 BREWER, GJ , (2009) THE USE OF COPPER-LOWERING THERAPY WITH TETRATHIOMOLYBDATE IN MEDICINE.EXPERT OPINION ON INVESTIGATIONAL DRUGS. VOL. 18. ISSUE 1. P. 89-97 21 38% 17

Classes with closest relation at Level 1


Rank Class id link
1 16871 CU ZN RATIO//NSECT//TRXRF
2 29118 OXIDATION OF DNA//ENDOGENOUS COPPER//PROOXIDANT ACTION
3 14925 DISULFIRAM//NEPICASTAT//DIETHYLDITHIOCARBAMATE
4 34812 GHK//GLY HIS LYS//GHK CU
5 4001 MEMBRANE SCI//SANDERS BROWN AGING//ALZHEIMERS DISEASE
6 4943 WILSONS DISEASE//ATP7B//HEPATOLENTICULAR DEGENERATION
7 2857 MENKES DISEASE//ATP7A//COPPER TRANSPORT
8 32265 CHAIR LIVESTOCK BIOTECHNOL//MCA RH7777//KLINIKUM RECHTS ISAR 2
9 29069 DIIODOQUIN//IODOQUINOL//8 HYDROXYQUINOLINE IN COSMETICS
10 12918 IRON METAB CHELAT PROGRAM//PYRIDOXAL ISONICOTINOYL HYDRAZONE//MOL PHARMACOL PATHOL PROGRAM

Go to start page